Long-term survival after allogeneic stem cell transplantation for advanced stage multiple myeloma
Author:
Affiliation:
1. Department of Haematology; Cliniques universitaires Saint-Luc; UCL; Brussels Belgium
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12881/fullpdf
Reference9 articles.
1. A comparison of allografting with autografting for newly diagnosed myeloma;Bruno;New England Journal of Medicine,2007
2. San Miguel J, Perez-Simon JA. Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post)-allogeneic transplantation for high-risk myeloma patients;Caballero-Velazquez;British Journal of Haematology,2013
3. Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse ratescompared with myeloablative conditioning;Crawley;Blood,2007
4. Nagler. Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions;Danylesko;Clinical & Developmental Immunology,2012
5. Donor cell leukemia developing after haematopoietic stem cell transplantation for multiple myeloma;Havelange;Acta Clinica Belgica,2006
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years;Frontiers in Oncology;2024-07-31
2. Successful Treatment of Relapsed/Refractory Extramedullary Multiple Myeloma With Anti-BCMA CAR-T Cell Therapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report and a Review of the Contemporary Literature;Frontiers in Medicine;2021-05-07
3. The Singapore Myeloma Study Group Consensus Guidelines for the management of patients with multiple myeloma;Singapore Medical Journal;2017-02
4. Chimeric Antigen Receptor (CAR) therapy for multiple myeloma;British Journal of Haematology;2016-01-20
5. Monocyte recovery at day 100 is associated with improved survival in multiple myeloma patients who undergo allogeneic hematopoietic cell transplantation;Bone Marrow Transplantation;2015-10-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3